Published in Hum Genet on January 26, 2013
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One (2016) 1.44
Genetic diversity of disease-associated loci in Turkish population. J Hum Genet (2015) 0.76
Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics. BMC Genomics (2014) 0.75
Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour (2010) 42.87
Genetic structure of human populations. Science (2002) 30.91
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Worldwide human relationships inferred from genome-wide patterns of variation. Science (2008) 22.44
adegenet: a R package for the multivariate analysis of genetic markers. Bioinformatics (2008) 13.99
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genotype, haplotype and copy-number variation in worldwide human populations. Nature (2008) 12.40
The genetic structure and history of Africans and African Americans. Science (2009) 10.65
Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad Sci U S A (2005) 10.22
The evolutionary significance of cis-regulatory mutations. Nat Rev Genet (2007) 9.35
Signals of recent positive selection in a worldwide sample of human populations. Genome Res (2009) 8.38
Discriminant analysis of principal components: a new method for the analysis of genetically structured populations. BMC Genet (2010) 7.67
Population genetic structure of variable drug response. Nat Genet (2001) 6.35
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77
Medical genetics: a marker for Stevens-Johnson syndrome. Nature (2004) 5.43
Standardized subsets of the HGDP-CEPH Human Genome Diversity Cell Line Panel, accounting for atypical and duplicated samples and pairs of close relatives. Ann Hum Genet (2006) 5.42
Features of evolution and expansion of modern humans, inferred from genomewide microsatellite markers. Am J Hum Genet (2003) 5.14
Genetic variation and population structure in native Americans. PLoS Genet (2007) 4.87
The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet (2008) 4.79
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet (2009) 4.32
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet (1993) 3.78
Clinical importance of the cytochromes P450. Lancet (2002) 3.77
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med (2001) 3.45
The role of geography in human adaptation. PLoS Genet (2009) 3.41
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther (2007) 3.35
Implications of biogeography of human populations for 'race' and medicine. Nat Genet (2004) 3.34
CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet (2004) 3.32
SNPper: retrieval and analysis of human SNPs. Bioinformatics (2002) 3.30
A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem (1999) 2.78
Adaptive evolution of UGT2B17 copy-number variation. Am J Hum Genet (2008) 2.58
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia (2007) 2.55
Spatial patterns of variation due to natural selection in humans. Nat Rev Genet (2009) 2.18
Adaptations to climate-mediated selective pressures in humans. PLoS Genet (2011) 2.15
A genome-wide association study of acenocoumarol maintenance dosage. Hum Mol Genet (2009) 1.78
Cytochromes P450, drugs, and diseases. Mol Interv (2003) 1.66
Genome-wide insights into the patterns and determinants of fine-scale population structure in humans. Am J Hum Genet (2009) 1.64
Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet (2004) 1.61
Comment on "Genetic structure of human populations". Science (2003) 1.57
Population genetics, history, and health patterns in native americans. Annu Rev Genomics Hum Genet (2004) 1.50
The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl Recept Signal (2009) 1.41
Inferring genetic ancestry: opportunities, challenges, and implications. Am J Hum Genet (2010) 1.36
Non-Darwinian estimation: my ancestors, my genes' ancestors. Genome Res (2009) 1.35
Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets (2006) 1.30
Rapid birth-death evolution specific to xenobiotic cytochrome P450 genes in vertebrates. PLoS Genet (2007) 1.26
Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics (2009) 1.23
Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. Am J Hum Genet (2006) 1.23
The nuclear receptor PXR: a master regulator of "homeland" defense. Crit Rev Eukaryot Gene Expr (2002) 1.10
Human genome diversity: frequently asked questions. Trends Genet (2010) 1.05
DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection. Am J Hum Genet (2002) 1.03
Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J (2006) 1.00
Molecular genetics of salt-sensitivity and hypertension. Drug Metab Dispos (2001) 0.96
Application of principal component analysis to pharmacogenomic studies in Canada. Pharmacogenomics J (2009) 0.94
Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians. Pharmacogenomics J (2010) 0.92
Pharmacogenomics of anti-TB drugs-related hepatotoxicity. Pharmacogenomics (2008) 0.92
Socioeconomic and nutritional factors account for the association of gastric cancer with Amerindian ancestry in a Latin American admixed population. PLoS One (2012) 0.91
Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine. Environ Health Perspect (2009) 0.85
Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet Genomics (2010) 0.84
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. Pharmacogenomics (2010) 0.84
Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions. Pharmacogenet Genomics (2007) 0.83
HLA alleles and drug hypersensitivity reactions. Int J Immunogenet (2011) 0.80
The blood-group frequencies of European peoples, and racial origins. 1940. Hum Biol (1990) 0.79
Conference Scene: The great debate: genome-wide association studies in pharmacogenetics research, good or bad? Pharmacogenomics (2010) 0.79
The population genetics of Quechuas, the largest native South American group: autosomal sequences, SNPs, and microsatellites evidence high level of diversity. Am J Phys Anthropol (2012) 0.78
A missense mutation (GGC[435Gly]-->AGC[Ser]) in exon 8 of the CYP11B2 gene inherited in Japanese patients with congenital hypoaldosteronism. Horm Res (2003) 0.77
CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics (2007) 1.97
Tracing past human male movements in northern/eastern Africa and western Eurasia: new clues from Y-chromosomal haplogroups E-M78 and J-M12. Mol Biol Evol (2007) 1.69
Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics (2009) 1.23
Mitochondrial diversity in linguistic isolates of the Alps: a reappraisal. Hum Biol (2002) 1.05
Genetic variation in Northern Thailand Hill Tribes: origins and relationships with social structure and linguistic differences. BMC Evol Biol (2007) 0.96
CYP2D6 genotyping by a multiplex primer extension reaction. Clin Chem (2005) 0.95
Genetic structure of the Mon-Khmer speaking groups and their affinity to the neighbouring Tai populations in Northern Thailand. BMC Genet (2011) 0.94
BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors. Eur J Clin Pharmacol (2011) 0.84